Post Herpetic Neuralgia Therapies Market Report – Research, Industry Analysis Reports and Market Demands

Global Post Herpetic Neuralgia Therapies Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Post Herpetic Neuralgia Therapies Market Report (Status and Outlook)

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Post Herpetic Neuralgia Therapies Market Size 2014-2024
- 2.1.2 Post Herpetic Neuralgia Therapies Market Size CAGR by Region
2.2 Post Herpetic Neuralgia Therapies Segment by Type
- 2.2.1 Drugs
- 2.2.2 Patches
- 2.2.3 Steroid Injectable
2.3 Post Herpetic Neuralgia Therapies Market Size by Type
- 2.3.1 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type (2014-2019)
2.4 Post Herpetic Neuralgia Therapies Segment by Application
- 2.4.1 Hospital Pharmacies
- 2.4.2 Online Pharmacies
- 2.4.3 Retail Pharmacies
2.5 Post Herpetic Neuralgia Therapies Market Size by Application
- 2.5.1 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Application (2014-2019)

3 Global Post Herpetic Neuralgia Therapies by Players

3.1 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Players
- 3.1.1 Global Post Herpetic Neuralgia Therapies Market Size by Players (2017-2019)
- 3.1.2 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Players (2017-2019)
3.2 Global Post Herpetic Neuralgia Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Post Herpetic Neuralgia Therapies by Regions

4.1 Post Herpetic Neuralgia Therapies Market Size by Regions
4.2 Americas Post Herpetic Neuralgia Therapies Market Size Growth
4.3 APAC Post Herpetic Neuralgia Therapies Market Size Growth
4.4 Europe Post Herpetic Neuralgia Therapies Market Size Growth
4.5 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Growth

5 Americas

5.1 Americas Post Herpetic Neuralgia Therapies Market Size by Countries
5.2 Americas Post Herpetic Neuralgia Therapies Market Size by Type
5.3 Americas Post Herpetic Neuralgia Therapies Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Post Herpetic Neuralgia Therapies Market Size by Countries
6.2 APAC Post Herpetic Neuralgia Therapies Market Size by Type
6.3 APAC Post Herpetic Neuralgia Therapies Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Post Herpetic Neuralgia Therapies by Countries
7.2 Europe Post Herpetic Neuralgia Therapies Market Size by Type
7.3 Europe Post Herpetic Neuralgia Therapies Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Post Herpetic Neuralgia Therapies by Countries
8.2 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Type
8.3 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Post Herpetic Neuralgia Therapies Market Forecast

10.1 Global Post Herpetic Neuralgia Therapies Market Size Forecast (2019-2024)
10.2 Global Post Herpetic Neuralgia Therapies Forecast by Regions
- 10.2.1 Global Post Herpetic Neuralgia Therapies Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
10.7 Global Post Herpetic Neuralgia Therapies Forecast by Type
10.8 Global Post Herpetic Neuralgia Therapies Forecast by Application

11 Key Players Analysis

11.1 Endo Pharmaceuticals
- 11.1.1 Company Details
- 11.1.2 Post Herpetic Neuralgia Therapies Product Offered
- 11.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Endo Pharmaceuticals News
11.2 Depomed
- 11.2.1 Company Details
- 11.2.2 Post Herpetic Neuralgia Therapies Product Offered
- 11.2.3 Depomed Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Depomed News
11.3 Acorda Therapeutics
- 11.3.1 Company Details
- 11.3.2 Post Herpetic Neuralgia Therapies Product Offered
- 11.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Acorda Therapeutics News
11.4 Pfizer
- 11.4.1 Company Details
- 11.4.2 Post Herpetic Neuralgia Therapies Product Offered
- 11.4.3 Pfizer Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Pfizer News
11.5 Mylan
- 11.5.1 Company Details
- 11.5.2 Post Herpetic Neuralgia Therapies Product Offered
- 11.5.3 Mylan Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Mylan News
11.6 Daiichi Sankyo
- 11.6.1 Company Details
- 11.6.2 Post Herpetic Neuralgia Therapies Product Offered
- 11.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Daiichi Sankyo News
11.7 Teikoku Pharma
- 11.7.1 Company Details
- 11.7.2 Post Herpetic Neuralgia Therapies Product Offered
- 11.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Teikoku Pharma News

...

12 Research Findings and Conclusion

Description

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

According to this study, over the next five years the Post Herpetic Neuralgia Therapies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Post Herpetic Neuralgia Therapies business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Post Herpetic Neuralgia Therapies market by product type, application, key companies and key regions.

This study considers the Post Herpetic Neuralgia Therapies value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Drugs
Patches
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Endo Pharmaceuticals
Depomed
Acorda Therapeutics
Pfizer
Mylan
Daiichi Sankyo
Teikoku Pharma
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Post Herpetic Neuralgia Therapies market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Post Herpetic Neuralgia Therapies market by identifying its various subsegments.
Focuses on the key global Post Herpetic Neuralgia Therapies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Post Herpetic Neuralgia Therapies with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Post Herpetic Neuralgia Therapies submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.